Satellite Banner
Technology Networks Header
Sunday, September 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Cancer Diagnostic Device
Thursday, May 29, 2014
Commercial launch of a new system to improve cancer diagnosis and treatment.

Debiopharm Moves Forward Three of its Oncology Clinical Programs
Thursday, May 29, 2014
Company will present the recent progresses at the 50th American Society of Clinical Oncology Annual Meeting.

Powerful Tool for Genomic Editing
Friday, May 23, 2014
CRISPR/Cas9 - Designed to produce a genetically modified cell.

Next-Generation Flow Cytometry Instrument Broadens Analysis in Life Science Research
Thursday, May 22, 2014
Life Technologies Attune NxT Acoustic Focusing Cytometer expands capabilities, features modular design to fit any lab’s budget and research.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

Vitamin-mediated Cell Delivery of Oligonucleotides – an Attractive Approach for Therapeutic Applications
Wednesday, May 21, 2014
Link Technologies Ltd has announced the availability of a novel vitamin modifier, which has shown in initial tests to have the potential of improving cell delivery of oligonucleotides.

N-of-One to Provide Clinical Interpretation for Guardant360™ Tests
Monday, May 19, 2014
Breakthrough blood test enables next generation sequencing of solid tumor DNA.

Bespoke Instrumentation and Custom Manufacturing from Bibby Scientific
Wednesday, May 14, 2014
The company can produce solutions which directly meet with customer specs, ensuring that they get the results they require in the most accurate and reliable way possible.

Exiqon Launches XploreRNA™ app for Advanced Cross-Database Queries
Tuesday, May 13, 2014
XploreRNA™ will soon be available on Android and Windows platforms.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 651
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv